Allenamide Cysteine Modification via Electron-Deficient Alkynes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modifying cysteine residues in proteins lack selectivity and reversibility, especially in biological environments, and there is a need for a versatile reaction that does not require special local conditions or metal catalysis.
Innovation Solution
A compound of formula I, which includes various substituents and can form irreversible bonds with free thiol groups, particularly cysteine residues, in aqueous media and physiological conditions, without the need for metal catalysis or special local conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If classical reagents (maleimides, acrylamides) are used to modify cysteine residues, then the modification reaction can proceed under biological conditions, but the reactions lack selectivity and produce toxic by-products
Solution Approach 1:
The patent changes the chemical parameters of the reagent by using electron-deficient alkynes with specific electronic properties (electron-withdrawing groups at positions 1 and 3 of the alkyne). This parameter change enables the reagent to react selectively with cysteine thiols under physiological conditions while avoiding non-specific reactions with other nucleophiles, thus resolving the contradiction between biological compatibility and selectivity
2Reliability
If electron deficient alkynes are used to modify cysteine, then excellent selectivity is achieved, but the reaction becomes reversible in the presence of excess thiol
Solution Approach 1:
The patent creates a composite chemical structure by combining an electron-deficient alkyne core with specific electron-withdrawing substituents at positions 1 and 3. This composite structure achieves both high selectivity for cysteine and irreversibility of the modification reaction, even in the presence of excess thiol, by tuning the electronic properties to favor irreversible bond formation
3Reliability
If metal catalyzed reactions are used to modify cysteine, then excellent selectivity is achieved, but metal complexes are required which are unfit for many biological applications
Solution Approach 1:
The patent substitutes the mechanical/catalytic system (metal catalysts) with a chemical system based on electron-deficient alkynes. The chemical reactivity is driven by the electronic properties of the alkyne and its substituents rather than metal catalysis, eliminating metal toxicity while maintaining high selectivity for cysteine modification under physiological conditions
4Ease of operation
If reversible thiol-alkyne coupling is used, then the reaction can be controlled, but it cannot be applied in-vivo due to presence of excess glutathione
Solution Approach 1:
The patent changes the chemical parameters of the thiol-alkyne coupling reaction by introducing specific electron-withdrawing groups that alter the reaction equilibrium toward irreversible bond formation. This parameter change enables the reaction to proceed irreversibly even in the presence of excess glutathione, making in-vivo applications feasible while retaining controllability through the electronic properties of the reagent
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound selectively and irreversibly binds to cysteine residues, demonstrating excellent selectivity and stability, even in the presence of excess glutathione, making it suitable for in-vivo applications and various medical treatments.
Implementation Method 1
the thiol group attacks the carbon-carbon triple bond of the alkyne in a nucleophilic attack
Data Source
AI summary
There is provided a compound of formula I, having the structure: wherein R1 to R5 have the meanings given in the description.